Meeting Banner
Abstract #0861

Perfusion MRI Accurately Guides the Biopsy of Tumor-Rich Tissue During Stereotactic Biopsy

B. J. Mulligan1, I. S. Grunfeld1, L. C. Baxter1, J. M. Eschbacher2, A. C. Dueck3, S. Liu1, K. A. Smith4, S. W. Coons2, J. E. Heiserman5, J. P. Karis5, J. Debbins1, P. Nakaji4, L. S. Hu, 16

1Neuroimaging Research, Barrow Neurological Institute, Phoenix, AZ, United States; 2Neuropathology, Barrow Neurological Institute; 3Biostatistics, Mayo Clinic Arizona; 4Neurosurgery, Barrow Neurological Institute; 5Neuroradiology, Barrow Neurological Institute; 6Radiology, Mayo Clinic Arizona

Increasing the likelihood of collecting tumor-rich samples during surgery would greatly help the diagnosis and management of high grade gliomas (HGG). We examined the utility of using Perfusion MRI (pMRI) to guide stereotactic biopsy in cases of recurrent tumor. A pMRI Fractional Tumor Burden (pMRI-FTB) was calculated from the relative Cerebral Blood Volume to differentiate between post-treatment radiation effect (PTRE) and HGG recurrence. pMRI-FTB showed strong correlation with the biopsy-derived histologic tumor fraction (r = 0.90), indicating that this may be a useful method for guiding surgical biopsies.

Abstract PDF

Keywords

abstract accuracy accurate accurately adequacy adequate admixture agreement analyses assessment barrow biomedical biopsies biopsy biostatistics brain cancer capture cause cerebral challenge classifications classified clinic clinical cohort collected collection commission confidence considering content continued contrast coons correlated correlation critical critically currently developed diagnosis differentiate disagreement documented either enable enabling enhanced enhancing error errors examples feasibility fractional gold grade gradient greater guide guided heterogeneity identified implemented imported improve inflammation institute intervals isolating issue lack leading lesion likelihood localization maps material matrix mayo medium molecular much mulligan naive necessary negative neurological neuropathology neurosurgery novel orange overall overlays part patients percentage perfusion phoenix platform post potential predict predictive preoperative prior prognostication prospective prospectively quantification radiation radiology recruited recurrence recurrent refocused related reliable reliably report response rich samples screen section selection sensitivity sets setting site specificity specimens spoiled stealth subcomponents subregions sufficient suite surgical target targets thereby thresholding tissue treatment tumor tumors usually volume whereby white